Swan Life Ltd (MUSE:ANGM.I0000)
Mauritius · Delayed Price · Currency is MUR 1,550.00
0.00 (0.00%)
At close: Mar 17, 2026
Swan Life Income Statement
Financials in millions MUR. Fiscal year is January - December.
Millions MUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Premiums & Annuity Revenue | 2,449 | 2,212 | 520.19 | 257.46 | 4,957 | 4,532 |
Total Interest & Dividend Income | - | - | 259.95 | 367.31 | 1,456 | 1,168 |
Gain (Loss) on Sale of Investments | - | - | 28.95 | - | 941.06 | 1,242 |
Other Revenue | - | - | 463.03 | 389.81 | 401.25 | 549.91 |
| 2,449 | 2,212 | 1,272 | 1,015 | 7,755 | 7,492 | |
Revenue Growth (YoY) | 84.98% | 73.89% | 25.38% | -86.92% | 3.52% | 4.56% |
Policy Benefits | 1,995 | 1,809 | - | - | 3,470 | 3,409 |
Policy Acquisition & Underwriting Costs | - | - | - | - | 189.9 | 183.96 |
Depreciation & Amortization | - | - | - | - | 45.21 | 50.22 |
Selling, General & Administrative | - | - | - | - | 545.43 | 472.38 |
Provision for Bad Debts | - | - | - | - | 11.82 | 34.9 |
Other Operating Expenses | -279.52 | -433.49 | 470.88 | 443.73 | 129.95 | 106.3 |
Total Operating Expenses | 1,716 | 1,376 | 470.88 | 443.73 | 4,398 | 4,267 |
Operating Income | 732.96 | 836.32 | 801.23 | 570.85 | 3,357 | 3,224 |
Interest Expense | - | - | -45.78 | -0.58 | -0.57 | -1.58 |
Earnings From Equity Investments | - | - | -0.68 | 0.57 | 0.74 | -9.27 |
Currency Exchange Gain (Loss) | - | - | -25.43 | 1.81 | 264.76 | 133.56 |
EBT Excluding Unusual Items | 732.96 | 836.32 | 729.35 | 572.65 | 3,622 | 3,347 |
Gain (Loss) on Sale of Assets | - | - | 6.52 | 11.09 | 0.15 | -0.93 |
Asset Writedown | - | - | - | - | -0.2 | -9.36 |
Pretax Income | 732.96 | 836.32 | 735.87 | 583.74 | 3,622 | 3,337 |
Income Tax Expense | 71.69 | 74.75 | 59.66 | 29.48 | 54.52 | 3.65 |
Earnings From Continuing Ops. | 661.27 | 761.57 | 676.21 | 554.25 | 3,568 | 3,333 |
Minority Interest in Earnings | -77.1 | -75.39 | -53.11 | -47.09 | -54.46 | -39.78 |
Net Income | 584.17 | 686.18 | 623.1 | 507.17 | 3,513 | 3,293 |
Preferred Dividends & Other Adjustments | - | - | - | - | 2,938 | 2,776 |
Net Income to Common | 584.17 | 686.18 | 623.1 | 507.17 | 575.14 | 517.69 |
Net Income Growth | -14.25% | 10.12% | 22.86% | -85.56% | 6.67% | 23.18% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Change (YoY) | - | 0.00% | - | - | - | - |
EPS (Basic) | 221.93 | 260.68 | 236.72 | 192.68 | 218.50 | 196.68 |
EPS (Diluted) | 221.93 | 260.68 | 236.72 | 192.68 | 218.50 | 196.68 |
EPS Growth | -14.25% | 10.12% | 22.86% | -11.82% | 11.10% | 32.09% |
Free Cash Flow | 2,616 | 5,115 | 2,989 | 2,054 | 2,361 | 1,856 |
Free Cash Flow Per Share | 993.77 | 1943.21 | 1135.48 | 780.29 | 897.07 | 705.19 |
Dividend Per Share | 75.900 | 75.900 | 69.010 | 65.340 | 59.400 | 59.400 |
Dividend Growth | 9.98% | 9.98% | 5.62% | 10.00% | - | - |
Operating Margin | 29.93% | 37.81% | 62.98% | 56.26% | 43.29% | 43.04% |
Profit Margin | 23.86% | 31.02% | 48.98% | 49.99% | 7.42% | 6.91% |
Free Cash Flow Margin | 106.82% | 231.23% | 234.95% | 202.44% | 30.45% | 24.78% |
EBITDA | - | - | 840.37 | 610.49 | 3,396 | 3,267 |
EBITDA Margin | - | - | 66.06% | 60.17% | 43.79% | 43.60% |
D&A For EBITDA | - | - | 39.13 | 39.64 | 38.84 | 42.18 |
EBIT | 732.96 | 836.32 | 801.23 | 570.85 | 3,357 | 3,224 |
EBIT Margin | 29.93% | 37.81% | 62.98% | 56.26% | 43.29% | 43.04% |
Effective Tax Rate | 9.78% | 8.94% | 8.11% | 5.05% | 1.50% | 0.11% |
Revenue as Reported | - | - | - | - | 8,025 | 7,625 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.